Business Wire Feed
Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials
LONDON & NEW YORK--(BUSINESS WIRE)--$CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced that tomorrow it will report new clinical data from two ongoing Phase 3 more...
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday
A new post-hoc analysis from the LIBERTY studies, presented at ECCO 2026, demonstrated that initiating subcutaneous (SC) infliximab (Remsima™ SC) after a treatment interruption following intravenous (IV) infliximab induction helps patients with Crohn’s disease (CD) more...
Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease
– MAJESTY, the first global Phase III study in primary membranous nephropathy, met its primary endpoint of complete remission at two years – – Up to 30% of people with membranous nephropathy progress to kidney more...
CWCI: COVID-19 Drove Recent Volatility in California Work Injury & Illness Trends
OAKLAND, Calif.--(BUSINESS WIRE)--#COVID19--After surging during the height of the COVID-19 pandemic, the number of nonfatal work injuries and illnesses in California returned to pre-pandemic levels in 2024 according to a California Workers’ Compensation Institute (CWCI) more...
Philadelphia Jury Returns $250,000 Verdict Against J&J in Latest Baby Powder-Ovarian Cancer Trial
Outcome marks the first of several trials scheduled for 2026PHILADELPHIA--(BUSINESS WIRE)--A jury in the Philadelphia Court of Common Pleas has found Johnson & Johnson (NYSE:JNJ) responsible for the company’s baby powder products contributing to the more...
CenterWell Completes Acquisition of MaxHealth From Arsenal Capital Partners
MaxHealth is a Florida-based primary care organization with a network of 82 owned and affiliated clinics, providing care to more than 80,000 patients in value-based care programs. CenterWell Senior Primary Care is the nation’s largest more...
Sabra Health Care REIT, Inc. to Attend Citi’s 2026 Global Property CEO Conference
TUSTIN, Calif.--(BUSINESS WIRE)--$SBRA #CITI--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chair and Chief Executive Officer; Michael Costa, the company’s Chief Financial Officer; Darrin Smith, the company’s Chief Investment more...
Ottawa projected to lose funding for 725 frontline health care staff and nearly 200 hospital beds by 2027-28: new report
Planned funding cuts by the provincial government will lengthen wait-times and worsen patient care in hospitals, warns CUPEOTTAWA--(BUSINESS WIRE)--As hospitals cut hundreds of jobs and eliminate vacant positions amidst budgetary constraints imposed by the Conservative more...
NAVR Expands Alliance to Include Medical Networks to Strengthen Veteran Access to Ethical, High-Quality Medical Support
WASHINGTON--(BUSINESS WIRE)--The National Association for Veterans Rights (NAVR) today announced the expansion of its Alliance to include a new Medical Network arm, marking a significant step forward in strengthening ethical, high-quality medical support for Veterans more...
Wolters Kluwer Unveils Plans for Medi-Span Expert AI to Advance Medication Intelligence for Digital Health
Model Context Protocol (MCP) now available to support development of AI agents with Medi-Span’s AI-ready, expert-curated medication data.WALTHAM, Mass.--(BUSINESS WIRE)--#ai--Wolters Kluwer Health today unveiled plans for Medi-Span® Expert AI, designed to deliver medication intelligence from more...
Mirion to Present at Citi’s 2026 Global Industrial Tech and Mobility Conference
ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chairman and Chief Executive Officer, Thomas Logan, and Chief Financial Officer and Medical Group President, Brian Schopfer, will present at Citi’s 2026 Global Industrial Tech and Mobility Conference. more...
Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--$anro #cns--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the completion of patient enrollment in its Phase more...
Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution
CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The more...
Valvoline Instant Oil Change℠ Supports Children’s Health in Arizona Through Concours in the Hills
LEXINGTON, Ky.--(BUSINESS WIRE)--Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in preventive automotive maintenance is proud to support Concours in the Hills, one of Arizona’s premier automotive events. Now in its twelfth year, the more...
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in Citi’s Unplugged Medtech and Life Sciences Access Day on February 26, 2026. Scott Ullem, chief financial officer, is scheduled to present at more...
Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRI in patients with uncontrolled asthma published in The Lancet Respiratory Medicine
WILMINGTON, Del.--(BUSINESS WIRE)--Full results from the positive Phase III KALOS and LOGOS trials published in The Lancet Respiratory Medicine showed AstraZeneca’s BREZTRI Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6μg)) demonstrated statistically significant and clinically meaningful improvements more...
Optometry Practices Elevate Patient Experience with RevolutionEHR’s Integrated, Modernized Patient Portal
A sleek, compliance-first patient portal that delivers smoother communication and a better patient experience.SAN DIEGO--(BUSINESS WIRE)--#ONCCompliant--RevolutionEHR, the leading cloud-based EHR and practice management platform for optometry, today announced early access to its re-designed patient portal more...
Paradigm Signs Definitive Agreement to Be Acquired by Patient Square Capital
WALNUT CREEK, Calif.--(BUSINESS WIRE)--Paradigm (“Paradigm” or the “Company”), a specialty care management organization focused on delivering solutions that improve outcomes for individuals with complex injuries and diagnoses, today announced that it has entered into a more...
Evommune Announces $125 Million Private Placement
PALO ALTO, Calif. & NEW YORK--(BUSINESS WIRE)--Evommune, Inc. (“Evommune” or the “Company”) (NYSE: EVMN), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced that it has entered more...
Ardent Health Announces Fourth Quarter and Full Year 2025 Results Conference Call and Webcast Date
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2025 results after the more...
Jamieson Wellness Inc. Announces Date of Fourth Quarter and Full Year 2025 Financial Results and Conference Call
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its fourth quarter and full year 2025 financial results after the market close on Thursday, February 26, 2026. more...
Cross Country Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Wednesday, March 4, 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Wednesday, March 4, 2026 at 5:00 P.M. Eastern more...
Enhabit Home Health & Hospice Announces Date of 2025 Fourth Quarter Earnings Call
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the fourth quarter and fiscal year ended Dec. 31, 2025, on March 4, more...
IDEXX Laboratories to Present at Two Institutional Investor Conferences
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 26, 9:55 am – 10:30 am EST – Mike Lane, Executive Vice President more...
Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States
The collaboration follows FDA 510(k) clearance for eyonis® LCS and aims to integrate high-performance lung cancer screening detection and diagnosis device into the clinical workflow through the Tempus Pixel platform.SOPHIA ANTIPOLIS, France & CHICAGO--(BUSINESS WIRE)--Regulatory more...